$7.80
0.8011.43%
At close: -
$7.86
0.060.77%
After Hours: 6:41 PM EDT
Comments
Loading...
Regenxbio Earnings Estimates, EPS & Revenue | NASDAQ:RGNX | Benzinga
Regenxbio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-1.170
Quarterly Revenue Estimate
$19.85M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$83.33M
Analyze the earnings history of Regenxbio using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RGNX | Regenxbio | -$1.38 | -$1.17 | — | — | $15.62M | $19.85M | — | — | 05/07/2025 | Get Alert |
| RGNX | Regenxbio | -$1.43 | -$1.08 | -$1.01 | 6.48% | $22.21M | $23.70M | $21.21M | -10.49% | 03/13/2025 | Get Alert |
| RGNX | Regenxbio | -$1.41 | -$1.12 | -$1.17 | -4.46% | $28.91M | $23.59M | $24.20M | 2.57% | 11/06/2024 | Get Alert |
| RGNX | Regenxbio | -$1.66 | -$1.29 | -$1.05 | 18.60% | $19.98M | $22.97M | $22.30M | -2.94% | 08/01/2024 | Get Alert |
| RGNX | Regenxbio | -$1.53 | -$1.26 | -$1.38 | -9.52% | $19.14M | $23.52M | $15.62M | -33.58% | 05/08/2024 | Get Alert |
| RGNX | Regenxbio | -$1.38 | -$1.27 | -$1.43 | -12.60% | $31.34M | $34.00M | $22.21M | -34.67% | 02/27/2024 | Get Alert |
| RGNX | Regenxbio | -$1.75 | -$1.49 | -$1.41 | 5.37% | $26.51M | $27.19M | $28.91M | 6.34% | 11/08/2023 | Get Alert |
| RGNX | Regenxbio | -$1.58 | -$1.26 | -$1.66 | -31.75% | $32.65M | $39.83M | $19.98M | -49.84% | 08/02/2023 | Get Alert |
| RGNX | Regenxbio | -$1.79 | -$1.54 | -$1.53 | 0.65% | $22.22M | $30.60M | $19.14M | -37.46% | 05/03/2023 | Get Alert |
| RGNX | Regenxbio | $6.67 | -$1.23 | -$1.38 | -12.20% | $398.65M | $37.45M | $31.34M | -16.30% | 02/28/2023 | Get Alert |
| RGNX | Regenxbio | -$1.37 | -$1.46 | -$1.75 | -19.86% | $30.77M | $30.81M | $26.51M | -13.95% | 11/03/2022 | Get Alert |
| RGNX | Regenxbio | -$1.36 | -$1.53 | -$1.58 | -3.27% | $22.04M | $26.79M | $32.65M | 21.87% | 08/03/2022 | Get Alert |
| RGNX | Regenxbio | -$1.20 | -$1.32 | -$1.58 | -19.70% | $18.88M | $29.21M | $22.22M | -23.94% | 05/04/2022 | Get Alert |
| RGNX | Regenxbio | -$1.24 | $4.71 | $6.67 | 41.61% | $21.45M | $271.74M | $398.65M | 46.70% | 03/01/2022 | Get Alert |
| RGNX | Regenxbio | $0.23 | -$1.08 | -$1.37 | -26.85% | $98.91M | $41.46M | $30.77M | -25.78% | 11/02/2021 | Get Alert |
| RGNX | Regenxbio | -$0.91 | -$1.12 | -$1.36 | -21.43% | $16.57M | $29.02M | $22.04M | -24.07% | 08/09/2021 | Get Alert |
| RGNX | Regenxbio | -$1.08 | -$1.28 | -$1.20 | 6.25% | $17.64M | $23.23M | $18.88M | -18.71% | 05/05/2021 | Get Alert |
| RGNX | Regenxbio | -$0.72 | -$0.43 | -$1.24 | -188.37% | $11.77M | $61.50M | $21.45M | -65.13% | 03/01/2021 | Get Alert |
| RGNX | Regenxbio | -$0.94 | -$1.01 | $0.23 | 122.77% | $14.70M | $21.37M | $98.91M | 362.85% | 11/04/2020 | Get Alert |
| RGNX | Regenxbio | -$0.04 | -$0.94 | -$0.91 | 3.19% | $7.88M | $22.07M | $16.57M | -24.94% | 08/06/2020 | Get Alert |
| RGNX | Regenxbio | -$0.89 | -$0.87 | -$1.08 | -24.14% | $884.00K | $18.45M | $17.64M | -4.37% | 05/07/2020 | Get Alert |
Regenxbio (RGNX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $-1.01 | $-1.08 | 6.48 % |
| Q3 | 2024-11-06 | $-1.17 | $-1.12 | -4.46 % |
| Q2 | 2024-08-01 | $-1.05 | $-1.29 | 18.6 % |
| Q1 | 2024-05-08 | $-1.38 | $-1.26 | -9.52 % |
Regenxbio (RGNX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $21.21M | $23.70M | -10.5 % |
| Q3 | 2024-11-06 | $24.20M | $23.59M | 2.57 % |
| Q2 | 2024-08-01 | $22.30M | $22.97M | -2.94 % |
| Q1 | 2024-05-08 | $15.62M | $23.52M | -33.6 % |
FAQ
When is Regenxbio (NASDAQ:RGNX) reporting earnings?
Regenxbio (RGNX) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on March 13, 2025 for Q4.
What were the latest earnings per share (EPS) for Regenxbio (NASDAQ:RGNX)?
The Actual EPS was $-1.01, which beat the estimate of $-1.08.
What were Regenxbio’s (NASDAQ:RGNX) revenues?
The Actual Revenue was $21.2M, which missed the estimate of $23.7M.
Browse earnings estimates, EPS, and revenue on all stocks.